Estimation of Alpha-Amylase in Smokers with and without Leukoplakia and Oral Cancer—A Comparative Study

Background: Alpha-amylase is an enzyme found in saliva that plays a crucial role in the initial stages of digestion. Its levels can be influenced by various factors, including lifestyle habits such as smoking. Materials and Methods: A total of 150 male subjects were recruited for this comparative st...

Full description

Saved in:
Bibliographic Details
Main Authors: Amit A. Basannavar, Ankita Bhargava, Alkananda Sahoo, Nidhi Dhakar, Rahul R. Shetty, Debanti Giri
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2024-12-01
Series:Journal of Pharmacy and Bioallied Sciences
Subjects:
Online Access:https://journals.lww.com/10.4103/jpbs.jpbs_690_24
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841544178447679488
author Amit A. Basannavar
Ankita Bhargava
Alkananda Sahoo
Nidhi Dhakar
Rahul R. Shetty
Debanti Giri
author_facet Amit A. Basannavar
Ankita Bhargava
Alkananda Sahoo
Nidhi Dhakar
Rahul R. Shetty
Debanti Giri
author_sort Amit A. Basannavar
collection DOAJ
description Background: Alpha-amylase is an enzyme found in saliva that plays a crucial role in the initial stages of digestion. Its levels can be influenced by various factors, including lifestyle habits such as smoking. Materials and Methods: A total of 150 male subjects were recruited for this comparative study and divided into three groups: 50 smokers without any oral lesions (group A), 50 smokers with leukoplakia (group B), and 50 smokers with oral cancer (group C). Salivary samples were collected from each participant and analyzed for alpha-amylase activity using the 2-chloro-4-nitrophenyl-β-D-maltotrioside (CNPG3) method. Data were statistically analyzed using ANOVA and post-hoc tests to compare the mean alpha-amylase levels between the groups. Results: The mean alpha-amylase levels were found to be 140 U/mL in group A, 180 U/mL in group B, and 220 U/mL in group C. Statistical analysis revealed a significant increase in alpha-amylase levels in smokers with leukoplakia and oral cancer compared to smokers without oral lesions (P < 0.05). Moreover, a significant difference was observed between group B and group C (P < 0.05), indicating progressively higher enzyme levels with the severity of the oral condition. Conclusion: The study demonstrates that salivary alpha-amylase levels are elevated in smokers with leukoplakia and oral cancer compared to those without these conditions.
format Article
id doaj-art-fb00c929958b42f5b49e3fa9514c980f
institution Kabale University
issn 0976-4879
0975-7406
language English
publishDate 2024-12-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Journal of Pharmacy and Bioallied Sciences
spelling doaj-art-fb00c929958b42f5b49e3fa9514c980f2025-01-12T14:10:56ZengWolters Kluwer Medknow PublicationsJournal of Pharmacy and Bioallied Sciences0976-48790975-74062024-12-0116Suppl 4S3200S320210.4103/jpbs.jpbs_690_24Estimation of Alpha-Amylase in Smokers with and without Leukoplakia and Oral Cancer—A Comparative StudyAmit A. BasannavarAnkita BhargavaAlkananda SahooNidhi DhakarRahul R. ShettyDebanti GiriBackground: Alpha-amylase is an enzyme found in saliva that plays a crucial role in the initial stages of digestion. Its levels can be influenced by various factors, including lifestyle habits such as smoking. Materials and Methods: A total of 150 male subjects were recruited for this comparative study and divided into three groups: 50 smokers without any oral lesions (group A), 50 smokers with leukoplakia (group B), and 50 smokers with oral cancer (group C). Salivary samples were collected from each participant and analyzed for alpha-amylase activity using the 2-chloro-4-nitrophenyl-β-D-maltotrioside (CNPG3) method. Data were statistically analyzed using ANOVA and post-hoc tests to compare the mean alpha-amylase levels between the groups. Results: The mean alpha-amylase levels were found to be 140 U/mL in group A, 180 U/mL in group B, and 220 U/mL in group C. Statistical analysis revealed a significant increase in alpha-amylase levels in smokers with leukoplakia and oral cancer compared to smokers without oral lesions (P < 0.05). Moreover, a significant difference was observed between group B and group C (P < 0.05), indicating progressively higher enzyme levels with the severity of the oral condition. Conclusion: The study demonstrates that salivary alpha-amylase levels are elevated in smokers with leukoplakia and oral cancer compared to those without these conditions.https://journals.lww.com/10.4103/jpbs.jpbs_690_24alpha-amylasebiomarkercomparative studyleukoplakiaoral cancersalivasmokers
spellingShingle Amit A. Basannavar
Ankita Bhargava
Alkananda Sahoo
Nidhi Dhakar
Rahul R. Shetty
Debanti Giri
Estimation of Alpha-Amylase in Smokers with and without Leukoplakia and Oral Cancer—A Comparative Study
Journal of Pharmacy and Bioallied Sciences
alpha-amylase
biomarker
comparative study
leukoplakia
oral cancer
saliva
smokers
title Estimation of Alpha-Amylase in Smokers with and without Leukoplakia and Oral Cancer—A Comparative Study
title_full Estimation of Alpha-Amylase in Smokers with and without Leukoplakia and Oral Cancer—A Comparative Study
title_fullStr Estimation of Alpha-Amylase in Smokers with and without Leukoplakia and Oral Cancer—A Comparative Study
title_full_unstemmed Estimation of Alpha-Amylase in Smokers with and without Leukoplakia and Oral Cancer—A Comparative Study
title_short Estimation of Alpha-Amylase in Smokers with and without Leukoplakia and Oral Cancer—A Comparative Study
title_sort estimation of alpha amylase in smokers with and without leukoplakia and oral cancer a comparative study
topic alpha-amylase
biomarker
comparative study
leukoplakia
oral cancer
saliva
smokers
url https://journals.lww.com/10.4103/jpbs.jpbs_690_24
work_keys_str_mv AT amitabasannavar estimationofalphaamylaseinsmokerswithandwithoutleukoplakiaandoralcanceracomparativestudy
AT ankitabhargava estimationofalphaamylaseinsmokerswithandwithoutleukoplakiaandoralcanceracomparativestudy
AT alkanandasahoo estimationofalphaamylaseinsmokerswithandwithoutleukoplakiaandoralcanceracomparativestudy
AT nidhidhakar estimationofalphaamylaseinsmokerswithandwithoutleukoplakiaandoralcanceracomparativestudy
AT rahulrshetty estimationofalphaamylaseinsmokerswithandwithoutleukoplakiaandoralcanceracomparativestudy
AT debantigiri estimationofalphaamylaseinsmokerswithandwithoutleukoplakiaandoralcanceracomparativestudy